Toward 3D printed microfluidic artificial lungs for veteran rehabilitation
面向退伍军人康复的 3D 打印微流体人工肺
基本信息
- 批准号:9349646
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:3D PrintAcuteAcute Lung InjuryAffectAirAnimal ModelAnimal TestingAnimalsAreaBiomimeticsBioreactorsBlast InjuriesBloodBlood PlateletsBlood VolumeBlood capillariesBlood flowBlood gasCaliberCellsChemicalsChromiumChronicChronic Obstructive Airway DiseaseClinicalDevelopmentDevicesDiagnosisDialysis procedureDimensionsDiseaseDustEngineeringExhibitsExperimental DesignsFailureFiltrationForeign BodiesFreedomGasesGeometryGoalsGulf WarHealthcare SystemsHourHumanIn VitroLaboratoriesLengthLungLung diseasesMechanicsMicrofabricationMicrofluidic MicrochipsMicrofluidicsModelingNaturePaintPatientsPerformancePhotosensitivityPolyethylene GlycolsPolymersPopulationPositioning AttributePrintingProcessProductionRattusRehabilitation therapyReportingResearch ProposalsResistanceResolutionRespiratory SystemServicesSurfaceSurveysSystemTechniquesTechnologyTestingThickTimeTranslatingVeteransartificial lungbiomaterial compatibilityblood fractionationblood pumpcapillaryclinical applicationcostdesigndisabilityexperienceimprovedin vivooperationpolydimethylsiloxaneportabilitypressurepulmonary rehabilitationrespiratoryresponsescale upshear stresssmoke inhalationsurface coatingtechnology developmenttwo-dimensionalvirtual
项目摘要
The long-term goal of this technology development project is improve the rehabilitation of veterans suffering
from lung diseases through the development of the first truly portable, biocompatible, artificial lung capable of
short and long term respiratory support. Artificial lungs are currently used to rehabilitate lung disease patients;
however, significant advances in gas exchange, biocompatibility, and portability are required to fully realize
their potential. Microfluidic artificial lungs promise to enable a new class of truly portable artificial lungs through
feature sizes and blood channel designs that more closely mimic those found in their natural counterpart. Our
small-scale microfluidic artificial lungs achieved the highest gas exchange efficiency of any artificial lung to
date. Their lifetimes were significantly improved through the application of biocompatible surface coatings.
Initial in vivo demonstrations were performed in an animal (rat) model. However, current microfabrication
techniques limit the microfluidic networks in these devices to two dimensions, thereby severely limiting
potential device topologies and resulting in inefficient blood distribution networks. Further, current construction
techniques may not be suitable for the large area production required for human applications. In this study, we
will for the first time harness high resolution 3D polymer printing technology to create large area microfluidic
lungs with truly three dimensional blood flow networks and topologies. Constructed 3D printed microfluidic
artificial lungs will exhibit gas exchange suitable for some human applications, while using a fraction of the
blood contacting surface area, blood volume, and total volume of current commercial devices. The objectives
of the current technology-development SPiRE proposal are thus to: 1) Determine optimal 3D printing
parameters for microfluidic artificial lungs; and, 2) Construct and test the first 3D printed microfluidic artificial
lung in the laboratory using whole animal blood. At the conclusion of this study, we will be ready to test our 3D
printed microfluidic artificial lungs in a large animal model. The listed objectives are thus critical to advancing
this promising technology towards initial acute systems for veteran pulmonary rehabilitation.
这项技术开发项目的长期目标是改善退伍军人的康复
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Allen Potkay其他文献
Joseph Allen Potkay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Allen Potkay', 18)}}的其他基金
3D Printed Microfluidic Artificial Lung for Veteran Rehabilitation
用于退伍军人康复的 3D 打印微流控人工肺
- 批准号:
10629531 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
- 批准号:
10043828 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A Wearable CO2 Removal Device for Veteran Rehabilitation from Lung Disease
用于肺病退伍军人康复的可穿戴式二氧化碳去除装置
- 批准号:
10631937 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A Wearable CO2 Removal Device for Veteran Rehabilitation from Lung Disease
用于肺病退伍军人康复的可穿戴式二氧化碳去除装置
- 批准号:
10424362 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
- 批准号:
10663779 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A Wearable CO2 Removal Device for Veteran Rehabilitation from Lung Disease
用于肺病退伍军人康复的可穿戴式二氧化碳去除装置
- 批准号:
10455005 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
- 批准号:
10268182 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Toward 3D printed microfluidic artificial lungs for veteran rehabilitation
面向退伍军人康复的 3D 打印微流体人工肺
- 批准号:
9922672 - 财政年份:2017
- 资助金额:
-- - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
-- - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship














{{item.name}}会员




